Neuronetics Net Income Over Time
| STIM Stock | USD 1.46 0.00 0.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Neuronetics Performance and Neuronetics Correlation. Neuronetics | Build AI portfolio with Neuronetics Stock |
Will Health Care Equipment & Supplies sector continue expanding? Could Neuronetics diversify its offerings? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Neuronetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 1.013 | Return On Assets | Return On Equity |
Neuronetics's market price often diverges from its book value, the accounting figure shown on Neuronetics's balance sheet. Smart investors calculate Neuronetics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Neuronetics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Analysis
Compare Neuronetics and related stocks such as Prenetics Global, Nyxoah, and Atlantic International Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRE | 142.3 M | 1.1 B | 1.1 B | 664 M | 1.1 B | 104.4 M | (20.1 M) | (20.1 M) | (20.1 M) | (20.1 M) | (1.9 M) | (174 M) | (190.5 M) | (62.7 M) | (46.3 M) | (41.7 M) | (39.6 M) |
| NYXH | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (10.4 M) | (9.1 M) | (9.5 M) | (12.2 M) | (27.6 M) | (31.2 M) | (43.2 M) | (59.2 M) | (53.3 M) | (50.6 M) |
| ATLN | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.7 M) | (2.9 M) | (2.5 M) | (1 M) | (40.8 M) | (3.2 M) | (15.3 M) | (135.5 M) | (121.9 M) | (115.8 M) |
| OABI | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (17.6 M) | (27 M) | (22.3 M) | (50.6 M) | (62 M) | (55.8 M) | (53 M) |
| CATX | (437.6 K) | (2.8 M) | (3.5 M) | (3.9 M) | (6 M) | (3.7 M) | (4.7 M) | (6.2 M) | (4.8 M) | (3.3 M) | (3.2 M) | (7.3 M) | (14.7 M) | (46.5 M) | (79.3 M) | (71.4 M) | (67.8 M) |
| OSUR | (2.6 M) | (8.8 M) | (15.1 M) | (11.2 M) | (4.6 M) | 8.2 M | 19.7 M | 30.9 M | 20.4 M | 16.7 M | (14.9 M) | (23 M) | (17.1 M) | 53.7 M | (19.5 M) | (22.4 M) | (21.3 M) |
| PROF | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (11.8 M) | (12.1 M) | (15 M) | (15.2 M) | (15.2 M) | (21.6 M) | (30.7 M) | (28.7 M) | (28.6 M) | (26.5 M) | (23.8 M) | (25 M) |
| CDXS | (18.7 M) | (16.6 M) | (30.9 M) | (41.3 M) | (19.1 M) | (7.6 M) | (8.6 M) | (23 M) | (10.9 M) | (11.9 M) | (24 M) | (21.3 M) | (33.6 M) | (76.2 M) | (65.3 M) | (58.7 M) | (55.8 M) |
| SGMO | (308 K) | (35.8 M) | (22.3 M) | (26.6 M) | (26.4 M) | (40.7 M) | (71.7 M) | (54.6 M) | (68.3 M) | (75.8 M) | (121.1 M) | (178.3 M) | (192.3 M) | (257.8 M) | (97.9 M) | (88.1 M) | (83.7 M) |
| GNFT | 2.2 M | (9.7 M) | (5.4 M) | (12.7 M) | (17 M) | (17.1 M) | (33.7 M) | (58.6 M) | (79.5 M) | (65.1 M) | (101.2 M) | 67.3 M | (23.7 M) | (28.9 M) | 1.5 M | 1.4 M | 1.4 M |
Neuronetics and related stocks such as Prenetics Global, Nyxoah, and Atlantic International Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Neuronetics financial statement analysis. It represents the amount of money remaining after all of Neuronetics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Neuronetics | STIM |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 3222 Phoenixville Pike, |
| Exchange | NASDAQ Exchange |
USD 1.46
Check out Neuronetics Performance and Neuronetics Correlation. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Neuronetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.